|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss attributable to Agrify Corporation | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt discount | |||||
| Amortization of debt issuance costs | |||||
| (Gain) loss attributable to non-controlling interests | |||||
| Non-cash interest expense | |||||
| Lease expense | |||||
| Impairment of right-of-use assets | |||||
| Impairment of long-lived assets | |||||
| Stock-based compensation expense | |||||
| Provision for doubtful accounts | |||||
| Loss on extinguishment of long-term debt, net | |||||
| Change in provision for credit losses, net | |||||
| (Recovery of) provision for slow-moving inventory | |||||
| Change in fair value of contingent consideration | |||||
| Change in provision for inventory | |||||
| (Gain) loss on disposal of property and equipment | |||||
| Change in inventory reserve | |||||
| Loss on abandonment of CIP projects | |||||
| Gain on disposal of property and equipment | |||||
| Gain on exit of Extraction business | |||||
| Gain on early termination of lease | |||||
| Gain on settlement of contingent liability | |||||
| Loss on disposal of Cultivation business | |||||
| Income attributable to non-controlling interests | |||||
| Change in contingent consideration | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Accounts receivable - related party | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accounts payable - related party | |||||
| Accrued expenses and other current liabilities | |||||
| Accrued expenses and other current liabilities - related party | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Contract liabilities | |||||
| Net cash and cash equivalents used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Related party transaction with MC Brands | |||||
| Related party transaction with VCP | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from disposal of property and equipment | |||||
| Issuance of loans receivable | |||||
| Proceeds from repayment of loan receivable | |||||
| Net cash and cash equivalents used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from related party notes payable | |||||
| Proceeds from third-party notes payable | |||||
| Repayments of third-party notes payable | |||||
| Repayment of debt in private placement | |||||
| Payments on other financing loans | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Proceeds from issuance of Common Stock through an S-1 and Pre-Funded Warrants offering | |||||
| Proceeds from issuance of Common Stock through IONIC Stock Subscription | |||||
| Proceeds from issuance of Common Stock through an “at the market” offering, net of fees | |||||
| Proceeds from issuance of Common Stock in connection with private placement, net | |||||
| Proceeds from Employee Stock Purchase Plan Shares | |||||
| Proceeds from exercise of Pre-Funded Warrants | |||||
| Payments on insurance financing loans | |||||
| Payments of financing leases | |||||
| Net cash and cash equivalents provided by financing activities continuing operations | |||||
| Net decrease in cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of period | |||||
| Cash and cash equivalents of discontinued operations, beginning of period | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | |||||
| Cash and cash equivalents at the end of period | |||||
| Cash and cash equivalents | |||||
| Supplemental disclosures | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing activities | |||||
| Initial fair value of warrants | |||||
| Conversion of related party debt to common stock | |||||
| Issuance of pre-funded warrants in lieu of related party shared services agreement | |||||
| Issuance of pre-funded warrants in lieu of related party cash interest | |||||
| Issuance of pre-funded warrants in lieu of cash interest | |||||
| Reclassification of accounts payable and accrued interests to notes payable | |||||
| Conversion of liability classified pre-funded warrants to equity | |||||
| Stock and warrants issued in connection with business combination | |||||
| Fair value of warrants in connection with reclassification and issuance | |||||
| Conversion of convertible notes into equity | |||||
| Cashless exercise of liability classified warrants | |||||
| Deemed contribution from troubled debt restructuring with related party | |||||
| Financing of prepaid insurance | |||||
| Conversion of related party debt to equity | |||||
| Transfer of property and equipment to inventory | |||||
Loading...